AstraZeneca PLC (GB:AZN)

AstraZeneca (AZN) Stock Price & Analysis


AZN Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range9,200.50p - 12,392.00p
Previous Close11,784p
Average Volume (3M)1.90M
Market Cap
Enterprise Value20.12T
Total Cash (Recent Filing)$6.24B
Total Debt (Recent Filing)$29.23B
Price to Earnings (P/E)46.4
Jul 27, 2023
1.97 (0.02%)
Share Statistics
EPS (TTM)2.54
Shares Outstanding1,549,800,030
10 Day Avg. Volume2,944,327
30 Day Avg. Volume1,904,080
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)-826.75
Price to Sales (P/S)515.44
Price to Cash Flow (P/CF)3807.90
P/FCF Ratio4173.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue453.73
Enterprise Value/Gross Profit629.63
Enterprise Value/Ebitda2.22K
Price Target Upside-9.85% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering12




What was AstraZeneca PLC’s price range in the past 12 months?
AstraZeneca PLC lowest stock price was 9200.50p and its highest was 12392.00p in the past 12 months.
    What is AstraZeneca PLC’s market cap?
    Currently, no data Available
    When is AstraZeneca PLC’s upcoming earnings report date?
    AstraZeneca PLC’s upcoming earnings report date is Jul 27, 2023 which is in 58 days.
      How were AstraZeneca PLC’s earnings last quarter?
      AstraZeneca PLC released its earnings results on Apr 27, 2023. The company reported 1.552p earnings per share for the quarter, beating the consensus estimate of 1.38p by 0.172p.
        Is AstraZeneca PLC overvalued?
        According to Wall Street analysts AstraZeneca PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AstraZeneca PLC pay dividends?
          AstraZeneca PLC pays a Annually dividend of 145.3p which represents an annual dividend yield of 2.03%. See more information on AstraZeneca PLC dividends here
            What is AstraZeneca PLC’s EPS estimate?
            AstraZeneca PLC’s EPS estimate is £1.59.
              How many shares outstanding does AstraZeneca PLC have?
              AstraZeneca PLC has 1,549,857,300 shares outstanding.
                What happened to AstraZeneca PLC’s price movement after its last earnings report?
                AstraZeneca PLC reported an EPS of 1.552p in its last earnings report, beating expectations of 1.38p. Following the earnings report the stock price went down -0.405%.
                  Which hedge fund is a major shareholder of AstraZeneca PLC?
                  Currently, no hedge funds are holding shares in GB:AZN


                  AstraZeneca Stock Smart Score

                  The AstraZeneca Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  AstraZeneca PLC

                  A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.


                  Top 5 ETFs holding AZN

                  Market Value
                  Smart Score
                  Vang FTSE 100 Ptg.Shs GBP
                  iShares MSCI United Kingdom ETF
                  UBS ETF MSCI UK Shs -A- Distribution
                  UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF A- Capitalisation
                  UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF (GBP) A-UKdis
                  Up to five ETFs with an Outperform Smart Score that hold AZN. The ETFs are listed according to market value of AZN within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Hikma Pharmaceuticals
                  Dechra Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis